How to access Xcopri from Oman, the named-patient import pathway, 2026
By Reserve Meds · Clinical & regulatory team · Last reviewed 2026-04-23
An Omani patient living with drug-resistant focal (partial-onset) epilepsy may receive a prescription for Xcopri (cenobamate) from their treating neurologist or epileptologist. Xcopri is FDA-approved for the treatment of partial-onset seizures in adults and is manufactured by SK Life Science. Its clinical data demonstrated seizure-freedom rates in trial subgroups that were notable in the epilepsy field, which is why it is often considered when patients have failed two or more conventional anti-seizure medications (ASMs). In Oman, Xcopri is not yet broadly registered, which is why your neurologist may be navigating a named-patient import pathway with you.
This guide explains the legal pathway, what your physician needs to provide, typical timelines, and where Reserve Meds fits in.
Ask about Xcopri in Oman
Tell us the medicine and your country. We reply within one business day. On WhatsApp we usually reply the same day.
The clinical situation
Xcopri is an oral tablet with a slow titration schedule, typically starting at 12.5 mg and increasing every two weeks to a target maintenance dose of 200 mg daily (with a maximum of 400 mg). Slow titration is critical: Xcopri carries a US warning about Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) and, like other ASMs, QT-shortening considerations for patients with family short-QT syndrome. Your treating epileptologist confirms diagnosis (drug-resistant focal epilepsy per ILAE criteria), prior ASM history, EKG baseline where indicated, and the titration schedule.
Case active and ready to skip the regulatory walkthrough? Ask about a medicine or WhatsApp us.
Is Xcopri legally importable into Oman?
Yes, through the Central Drugs Standard Control Organization (DGPADC) named-patient / personal-use import framework. The pathway allows an Omani-licensed physician or the patient directly (with physician prescription) to request import of a medicine not locally registered when: (a) the medicine is approved by a recognised reference authority (FDA qualifies), (b) no clinically equivalent registered alternative fits, (c) the physician takes clinical responsibility, and (d) the imported quantity is proportionate to a defined treatment period.
For Xcopri specifically, the application is routine, an oral tablet with standard room-temperature handling and no REMS complexity.
How the pathway works, step by step
- Consultation with your treating epileptologist. Diagnosis confirmation (drug-resistant focal epilepsy), prior ASM trial documentation, and titration plan.
- DGPADC named-patient / personal-use application. Your physician or the importing pharmacy files the application.
- US-side sourcing. Reserve Meds coordinates with our US-licensed pharmaceutical wholesale partner to secure the product from the manufacturer's authorised distribution chain.
- Shipment. Xcopri ships at controlled room temperature; no cold-chain is required.
- Arrival and titration start. The treating physician initiates and supervises the slow titration.
What documentation your physician needs
Your physician will typically need to provide:
- Clinical rationale letter confirming drug-resistant focal epilepsy, prior ASM history with outcomes, and Xcopri as the indicated next therapy
- Verification of Omani medical licence
- Patient identifier
- Planned titration schedule and projected monthly tablet count
- Baseline EKG where family short-QT syndrome is suspected
Reserve Meds provides a physician documentation kit that bundles the templates DGPADC reviewers expect to see.
Costs and timing
Medicine price: quote on request. You get a written quote for your case before you commit. Shipment, documentation, and coordination add incremental cost; Reserve Meds issues a full transparent quote at the start of intake.
We give you a written timeline estimate for your case before you commit. Titration typically runs 11 weeks from 12.5 mg to 200 mg, so your physician will plan multi-month supply accordingly.
If your clinical situation is time-sensitive, tell us at intake. We triage accordingly.
Reserve Meds's role
Reserve Meds is a US-based digital health company that coordinates access to cross-border specialty medicine. For Xcopri specifically, we provide:
- Sourcing. Through our US-licensed pharmaceutical wholesale partner, operating under DSCSA chain-of-custody.
- Documentation. Regulatory package for your physician and for DGPADC review.
- Logistics. Controlled-room-temperature shipment coordination.
- Dedicated case lead. A named point of contact.
What we do not do: We are not the prescriber. We do not practise medicine. We are not the dispensing pharmacy. All clinical decisions remain with your treating neurologist. Xcopri is not a controlled substance in the US DEA schedules, which simplifies cross-border handling.
Frequently asked
Is this legal in Oman? Yes, when executed through the DGPADC named-patient / personal-use framework with appropriate documentation. The pathway has been used routinely for specialty medicines not yet locally registered.
Why is titration so slow? Slow titration reduces the DRESS hypersensitivity-syndrome risk signalled in early clinical use of Xcopri. Your epileptologist will not rush it.
Can I combine Xcopri with my current anti-seizure medications? Yes, Xcopri is typically added to existing ASM regimens, and cross-titration with agents like carbamazepine, phenytoin, phenobarbital, or clobazam is managed by your neurologist because of enzyme-induction/inhibition interactions.
Will insurance cover this? Cash-pay is the default. Some Omani private insurers reimburse named-patient imports for drug-resistant epilepsy cases; we supply documentation but do not process claims directly.
Next step
For Xcopri coordination in Oman, start your case at the portal or message us on WhatsApp. We reply within one business day. On WhatsApp we usually reply the same day.
Examples and timings above are composite illustrations drawn from published sources and typical named-patient patterns. Your individual case is assessed by your physician and our clinical-regulatory team; Reserve Meds does not guarantee outcomes or timelines.
Reviewed by the Reserve Meds clinical operations team. Last reviewed: 2026-04-23.
Frequently asked questions
How can I get Xcopri in Oman if it is not approved or available there?
Reserve Meds coordinates US-sourced Xcopri for patients in Oman through a legal named-patient pathway, working with your treating doctor. Your treating physician provides the prescription and clinical justification; Reserve Meds prepares the named-patient documentation for Oman and arranges DSCSA-compliant US sourcing and delivery to your physician or hospital pharmacy.
Can I access Xcopri in Oman through a named-patient import?
Often, yes. Named-patient access (sometimes called personal import) is the legal route we use for FDA-approved medicines such as Xcopri. It is different from compassionate use, which covers investigational medicines through the manufacturer's own program; we do not supply investigational medicines. Eligibility and paperwork depend on the regulator in Oman, and Reserve Meds maps the specific pathway for each market it coordinates.
Do I need a prescription to access Xcopri in Oman through Reserve Meds?
Yes. Reserve Meds is not a pharmacy and does not prescribe. A valid prescription and clinical justification from your treating physician are required, and all clinical decisions remain with your physician.
How does Reserve Meds deliver Xcopri to a patient in Oman?
Medicines are supplied through a US-licensed pharmaceutical wholesale partner, and Reserve Meds coordinates delivery of Xcopri to your treating physician or hospital pharmacy in Oman, with appropriate handling for the product.
How long does it take, and what does Xcopri in Oman cost through Reserve Meds?
After a short intake, the clinical team responds within one business day with case-specific feasibility, an indicative timeline, and a formal written quote. Cost depends on the destination, the prescribed regimen, and the duration of therapy, and is confirmed in writing before anything proceeds.
How do I start a request for Xcopri in Oman?
Submit a 60-second intake through the Reserve Meds patient portal, or message our team on WhatsApp. We reply within one business day. On WhatsApp we usually reply the same day.